Xeris Biopharma Holdings, Inc. XERS Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s earnings yield?
- Xeris Biopharma Holdings, Inc. (XERS) reported earnings yield of 1.2% in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s earnings yield changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s earnings yield increased by 122.5% year-over-year, from -5.3% to 1.2%.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s earnings yield has grown at a -69.0% compound annual growth rate (CAGR), from -14.9% to 0%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.